MIRA INFORM REPORT

 

 

Report Date :

03.07.2013

 

IDENTIFICATION DETAILS

 

Name :

TEDIS

 

 

Registered Office :

8, Bis Rue Colbert Zac Des Montavas Wissous, 91320  

 

 

Country :

France

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

15.12.1989

 

 

Com. Reg. No.:

353148463

 

 

Legal Form :

Public Independent

 

 

Line of Business :

Wholesale of pharmaceutical goods

 

 

No. of Employees :

22

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

France

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

FRANCE - ECONOMIC OVERVIEW

 

The French economy is diversified across all sectors. The government has partially or fully privatized many large companies, including Air France, France Telecom, Renault, and Thales. However, the government maintains a strong presence in some sectors, particularly power, public transport, and defense industries. With at least 79 million foreign tourists per year, France is the most visited country in the world and maintains the third largest income in the world from tourism. France's leaders remain committed to a capitalism in which they maintain social equity by means of laws, tax policies, and social spending that reduce income disparity and the impact of free markets on public health and welfare. France's real GDP contracted 2.6% in 2009, but recovered somewhat in 2010 and 2011, before stagnating in 2012. The unemployment rate increased from 7.4% in 2008 to 10.3% in 2012. Youth unemployment shot up to 24.2% during the third quarter of 2012 in metropolitan France. Lower-than-expected growth and high unemployment costs have strained France's public finances. The budget deficit rose sharply from 3.4% of GDP in 2008 to 7.5% of GDP in 2009 before improving to 4.5% of GDP in 2012, while France's public debt rose from 68% of GDP to 89% over the same period. Under President SARKOZY, Paris implemented some austerity measures to bring the budget deficit under the 3% euro-zone ceiling by 2013 and to highlight France's commitment to fiscal discipline at a time of intense financial market scrutiny of euro-zone debt. Socialist Party candidate Francois HOLLANDE won the May 2012 presidential election, after advocating pro-growth economic policies, the separation of banks' traditional deposit taking and lending activities from more speculative businesses, increasing the top corporate and personal tax rates, and hiring an additional 60,000 teachers during his five-year term. The government's attempt to introduce a 75% wealth tax on income over one million euros for two years was struck down by the French Constitutional Council in December 2012 because it applied to individuals rather than households. France ratified the EU fiscal stability treaty in October 2012 and HOLLANDE's government has maintained France's commitment to meeting the budget deficit target of 3% of GDP during 2013 even amid signs that economic growth will be lower than the government's forecast of 0.8%. Despite stagnant growth and fiscal challenges, France's borrowing costs declined during the second half of 2012 to euro-era lows.

Source : CIA


Company name and address

Top of Form

Bottom of Form

Top of Form

 

Tedis

                                                                                                                                       

 

8, Bis Rue Colbert

Zac Des Montavas

 

Wissous, 91320

France

 

 

Tel:

+33 01 69 53 05 83

Fax:

+33 01 69 53 07 04

 

 

 

Employees:

22

Company Type:

Public Independent

 

 

Incorporation Date:

15-Dec-1989

Financials in:

 USD (mil)

Fiscal Year End:

31-Dec-2011

Reporting Currency:

Euro

Annual Sales:

45.2

Total Assets:

25.7

                                      

Business Description       

 

Tedis is primarily engaged in wholesale of pharmaceutical goods. This class also includes: wholesale of instruments and devices for doctors and hospitals; and wholesale of orthopaedic goods.

          

Industry                                                                                                                                      

 

Industry

Personal and Household Products

ANZSIC 2006:

3720 - Pharmaceutical and Toiletry Goods Wholesaling

NACE 2002:

5146 - Wholesale of pharmaceutical goods

NAICS 2002:

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

UK SIC 2003:

5146 - Wholesale of pharmaceutical goods

UK SIC 2007:

4646 - Wholesale of pharmaceutical goods

US SIC 1987:

5122 - Drugs, Drug Proprietaries, and Druggists' Sundries

                      

Key Executives           

   

 

Name

Title

Edith Edgard-Rosa

General manager

Marjorie Edgard-Rosa

General manager

Roland Marie Jean Edgard-Rosa

Chairman of the Board

1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7191895
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.770327

 

 


Corporate Overview

 

Location
8, Bis Rue Colbert
Zac Des Montavas
Wissous, 91320
France

 

Tel:

+33 01 69 53 05 83

Fax:

+33 01 69 53 07 04

 

Suggest Company URL

 

Sales EUR(mil):

32.5

Assets EUR(mil):

19.8

Employees:

22

Fiscal Year End:

31-Dec-2011

 

Industry:

Personal and Household Products

Incorporation Date:

15-Dec-1989

Company Type:

Public Independent

Quoted Status:

Not Quoted

Registered No.(FRA):

353148463

 

Chairman of the Board:

Roland Marie Jean Edgard-Rosa

 

 

 

Industry Codes

 

ANZSIC 2006 Codes:

3720

-

Pharmaceutical and Toiletry Goods Wholesaling

 

NACE 2002 Codes:

5146

-

Wholesale of pharmaceutical goods

 

NAICS 2002 Codes:

424210

-

Drugs and Druggists' Sundries Merchant Wholesalers

 

US SIC 1987:

5122

-

Drugs, Drug Proprietaries, and Druggists' Sundries

 

UK SIC 2003:

5146

-

Wholesale of pharmaceutical goods

 

UK SIC 2007:

4646

-

Wholesale of pharmaceutical goods

 

Business Description

Tedis is primarily engaged in wholesale of pharmaceutical goods. This class also includes: wholesale of instruments and devices for doctors and hospitals; and wholesale of orthopaedic goods.

 

 

 

 

 

 

 

Financial Data

Financials in:

EUR(mil)

 

Revenue:

32.5

Assets:

19.8

Current Assets:

17.5

 

Total Liabilities:

19.8

 

Issued Capital:

1.5

 

Net Worth:

6.8

 

 

 

Date of Financial Data:

31-Dec-2011

 

1 Year Growth

17.6%

NA

 

Key Corporate Relationships

Bank:

Bnp Paribas

 

 

 

 

 

 

 

 

 

 

 

Executives Report

 

Board of Directors

 

Name

Title

Function

Roland Marie Jean Edgard-Rosa

 

Chairman of the Board

Chairman

 

Executives

 

Name

Title

Function

Marjorie Edgard-Rosa

 

General manager

Administration Executive

Edith Edgard-Rosa

 

General manager

Administration Executive

 

Annual Profit & Loss

 

 

 

31-Dec-2011

31-Dec-2010

31-Dec-2009

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate (Period Average)

0.71919

0.755078

0.719047

Consolidated

No

No

No

 

 

 

 

Total income

45.4

37.1

30.5

Net sales

45.2

36.6

30.4

Change in stock

0.1

-0.1

-0.8

Subsidies for operating costs

-

-

0.1

Supplementary operating income

0.2

0.5

0.1

Other operating income

0.0

0.0

0.0

Other external charges

6.5

5.1

4.1

Cost of goods sold

29.6

24.5

21.6

Taxes and social security costs

0.4

0.3

0.3

Social charges

0.9

0.9

0.7

Total payroll costs

2.8

2.6

2.3

Cost of stock depreciation and amortisation

0.1

0.5

0.2

Fixed asset depreciation and amortisation

0.1

0.1

0.1

Other operating costs

0.2

0.2

0.0

Total operating costs

40.7

34.0

28.6

Net operating income

4.7

3.1

2.0

Total financial income

0.0

0.5

0.1

Interest payable on loans

0.1

0.2

0.2

Other expenses

0.0

0.4

0.1

Total expenses

0.1

0.5

0.2

Profit before tax

4.6

3.1

1.8

Extraordinary income

0.0

0.0

0.0

Extraordinary expenses

0.0

0.0

0.1

Extraordinary result

0.0

0.0

0.0

Total taxation

1.6

1.0

0.7

Net profit

3.1

2.1

1.1

 

 

 

Annual Balance Sheet

Financials in: USD (mil)

 

 

 

31-Dec-2011

31-Dec-2010

31-Dec-2009

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.770327

0.745406

0.696986

Consolidated

No

No

No

 

 

 

 

Issued capital

1.9

2.0

2.1

Share premium account

0.6

0.6

0.7

Total reserves

3.4

2.0

0.2

Profits for the year

2.9

2.1

1.1

Profit brought forward from previous year(s)

-

0.2

1.2

Total stockholders equity

8.8

6.9

5.4

Provisions and allowances

0.0

0.0

0.0

Trade creditors

9.3

7.6

9.1

Advances received

0.3

0.4

0.5

Bank loans and overdrafts

1.3

2.2

1.6

Current bank debts

0.3

0.7

0.4

Other loans

2.1

1.5

1.5

Other liabilities

2.6

3.3

3.2

Debts on fixed assets

0.1

-

-

Income stated in advance

-

-

0.0

Taxation and social security

1.1

1.2

1.0

Total current liabilities

15.6

14.6

15.6

Total debts

16.8

16.3

16.9

Regularisation account

0.0

0.0

0.0

Total liabilities (including net worth)

25.7

23.2

22.3

Patents

0.0

0.0

0.0

Other intangibles

0.0

-

-

Buildings

0.0

0.0

0.0

Other fixed assets

0.3

0.1

0.2

Long-term investments

0.4

0.1

0.1

Other financial assets

2.3

2.2

1.0

Total non-current assets

3.0

2.4

1.3

Prepayments

0.0

0.1

0.0

Net stocks and work in progress

2.0

2.1

2.1

Trade debtors

14.6

13.1

14.8

Other receivables

3.7

4.6

3.6

Prepaid expenses

0.1

0.1

0.1

Cash and liquid assets

2.2

0.8

0.3

Marketable securities

0.1

0.1

0.0

Total current assets

22.7

20.8

20.9

Prepaid expenses and deferred costs

0.0

0.0

0.0

Total assets

25.7

23.2

22.3

 



 

Annual Ratios

Financials in: USD (mil)

 

 

 

31-Dec-2011

31-Dec-2010

31-Dec-2009

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.770327

0.745406

0.696986

Consolidated

No

No

No

 

 

 

 

Current ratio

1.40

1.40

1.30

Quick ratio

1.30

1.30

1.20

Total liabilities to net worth

1.93%

2.38%

3.16%

Net worth to total assets

0.34%

0.30%

0.24%

Collection period

105.00

107.10

143.60

Stock turnover rate

21.10

17.30

15.20

Asset turnover

1.64%

1.60%

1.41%

Profit margin

0.10%

0.08%

0.06%

Return on assets

0.17%

0.14%

0.08%

Shareholders' return

0.49%

0.46%

0.35%

Sales per employee

8,526.23

8,238.76

5,968.05

Profit per employee

868.28

695.49

353.67

Average wage per employee

528.58

593.28

461.33

Net worth

8.8

6.9

5.4

Number of employees

25

22

24

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.41

UK Pound

1

Rs.90.38

Euro

1

Rs.77.61

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.